ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "B cells"

  • 2022 American Transplant Congress

    Pre-Emptive Rituximab Use for Epstein-Barr Virus (EBV) Viremia in Cardiothoracic Solid Organ Transplant Recipients

    B. Astorga, A. Loethen, L. Potter

    University of Chicago Medicine, Chicago, IL

    *Purpose: EBV viremia is associated with potentially life-threatening post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. The utility of rituximab for treating EBV viremia in…
  • 2022 American Transplant Congress

    Donor-Specificb Cell Dysfunction and Suppressive Ability Are Differentially Induced in Cob-Mediated Transplantation Tolerance

    S. Durgam1, D. Yin1, M. Alegre2, A. Chong1

    1Surgery, section of transplant immunology, University of Chicago, Chicago, IL, 2Medicine, section of rheumatology, University of Chicago, Chicago, IL

    *Purpose: B cells in mice tolerized to fully mismatched heart allografts with anti-CD154+donor spleen cells (CoB) are intrinsically dysfunctional and unable to differentiate into germinal…
  • 2022 American Transplant Congress

    Regulatory T and B Cell Responses Are Equally Compromised During Antibody-Mediated Rejection of Kidney Allografts

    K. Louis1, P. Fadakar2, C. Macedo2, M. Yamada2, M. Lucas2, X. Gu2, A. Zeevi2, P. Randhawa2, C. Lefaucheur3, D. Metes2

    1Inserm U976, Human Immunology and Immunopathology, Paris, France, 2Surgery, University of Pittsburgh, Pittsburgh, PA, 3Inserm U970, Paris Translational Research Center for Organ Transplantation, Paris, France

    *Purpose: Although considerable advances have been made in understanding the cellular effector mechanisms responsible for donor-specific antibody (DSA) generation leading to antibody-mediated rejection (ABMR), the…
  • 2022 American Transplant Congress

    Identification of a Human B Cell State with Allogeneic Antigen Cross-Presenting Potential

    U. Bhatia, E. C. Guinan

    Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA

    *Purpose: B cells are known to play a significant role in allograft tolerance or rejection, largely determined by production of cytokines and antibodies that suppress…
  • 2022 American Transplant Congress

    Optimal Development and Effector Function of Antibody-Suppressor CXCR5+CD8+ T Cells Requires Host IFN-γ and CD4+ T Cells

    J. Zimmerer, S. Chaudhari, M. Hart, J. Han, K. Koneru, G. Bumgardner

    OSUWMC, Columbus, OH

    *Purpose: We reported the discovery of a novel subset of CXCR5+IFNγ+CD8+ T cells that suppresses antibody production (CD8+ TAb-supp cells). Alloprimed CD8+ TAb-supp cells significantly…
  • 2022 American Transplant Congress

    Single Cell And Spatial Transcriptomics Of Blood And Biopsies Reveals Enhanced Alloantigen Presenting Function And T-follicular Helper Cell (tfh) Expansion Early After Pediatric Liver Transplantation

    R. Sindhi1, C. Ashokkumar1, M. Ningappa1, D. Rajasundaram1, B. W. Higgs1, Q. Xu2, A. Zeevi2, M. Reyes-Mugica1

    1Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: We have previously reported enhanced B-cell presentation of donor antigen during early T-cell mediated liver transplant (LT) rejection.*Methods: To characterize B-cell related immunological mechanisms…
  • 2022 American Transplant Congress

    Validation of Donor Specific Antibody Characteristics Associated with Deleterious Outcomes: A Single Center Study of 940 Kidney Allograft Recipients

    P. Lamba1, I. Lamba1, R. Friedlander2, V. Sharma3, J. Lee2, J. B. Lee4, C. Hartono5, M. Thangamani6, D. Sawinski2, T. Salinas7, M. Suthanthiran8, D. Dadhania9

    1Nephrology, Hypertension and Transplantation, New York Presbyterian/Weill Cornell Medicine, New York, NY, 2New York Presbyterian/Weill Cornell Medicine, New York, NY, 3The Rogosin Inst Cornell UMC, New York, NY, 4Rogosin Institute, New York, NY, 5New York Presbyterian Hospital-Weill Cornell, New York, NY, 6Cornell, New York, NY, 7Nephrology, NY Presbyterian- Weill Cornell, New York, NY, 8Weill Cornell Med Ctr., New York, NY, 9Weill Cornell Medicine - NYPH, New York, NY

    *Purpose: A reproducibility crisis is pervasive in scientific literature. We aimed to investigate whether the DSA characteristics we previously associated with antibody mediated rejection (AMR)…
  • 2022 American Transplant Congress

    Comparison of IGG and IGM Type B Cell Receptor-Mediated MTOR Phosphorylation Signal

    Y. Matsuda

    Division of Transplant Immunology, Division of Transplant Immunology, Tokyo, Japan

    *Purpose: IgG and IgM memory B cells (mBCs) corresponding donor-specific antigen are closely involved in the activation of humoral immunity against transplanted grafts. Therefore, it…
  • 2022 American Transplant Congress

    Local Intragraft Humoral Immune Response in Chronic Lung Allograft Dysfunction

    E. Miyamoto1, S. C. Juvet2, D. Vosoughi2, J. Wang2, J. Al-Refaee2, T. Daigneault2, A. Duong2, S. Moshkelgosha2, S. Keshavjee2, K. Tinckam2, A. Chruscinski3, D. Hwang4, T. Martinu2

    1Tenri Hospital Japan, University Health Network Canada, Nara, Japan, 2University Health Network, Toronto, ON, Canada, 3Multi-Organ Transplantation, University Health Network, Toronto, ON, Canada, 4Sunnybrook Health Science Centre, Toronto, ON, Canada

    *Purpose: Donor HLA-specific antibody (DSA) and antibody against self-antigens (self-antigen antibody) can cause injury and lead to chronic lung allograft dysfunction (CLAD) after lung transplantation…
  • 2022 American Transplant Congress

    CD40 Expressed by FRC Regulates Lymph Node Structure and Function

    M. W. Shirkey1, L. Li1, R. Abdi2, J. S. Bromberg1

    1University of Maryland School of Medicine, Baltimore, MD, 2Transplant Research Center, Harvard Medical School, Boston, MA

    *Purpose: Fibroblastic reticular cells (FRC) support lymph node (LN) structure and can regulate T cell function through the CD40-CD40L pathway. Our previous work showed that…
  • 1
  • 2
  • 3
  • …
  • 35
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences